BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/26/2024 3:04:22 AM | Browse: 41 | Download: 132
 |
Received |
|
2024-08-19 07:39 |
 |
Peer-Review Started |
|
2024-05-30 03:28 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-09-25 13:45 |
 |
Revised |
|
2024-10-09 00:44 |
 |
Second Decision |
|
2024-11-14 02:41 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-11-14 09:17 |
 |
Articles in Press |
|
2024-11-14 09:17 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2024-11-25 00:50 |
 |
Typeset the Manuscript |
|
2024-11-28 08:31 |
 |
Publish the Manuscript Online |
|
2024-12-26 03:04 |
ISSN |
2220-315x (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Genetic factors that predict response and failure of biologic therapy in Inflammatory Bowel Disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Milena Peruhova, Daniela Stoyanova, Dimitrina Georgieva Miteva, Meglena Kitanova, Milko Bozhidarov Mirchev and Tsvetelina Velikova |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
The European Union-Next Generation EU, through the National Recovery and Resilience Plan of the Republic of Bulgaria |
No. BG-RRP-2.004-0008 |
|
Corresponding Author |
Daniela Stoyanova, MD, Department of Gastroenterology, Military Medical Academy, Georgy Sofiysky Street 3, Sofia 1606, Bulgaria. d.stoyanova@mail.bg |
Key Words |
Inflammatory bowel disease; Genetic predictors; Inflammatory bowel disease treatment; Biologic therapy; Biologic therapy response; Genetic markers in inflammatory bowel disease; Inflammatory bowel disease treatment failure; Pharmacogenomics; Biologic therapy efficacy; Genetic variability |
Core Tip |
Understanding the genetic factors that influence the response and failure of biological therapy in Inflammatory Bowel Disease (IBD) is crucial for optimizing treatment strategies. Identifying specific genetic markers can help predict patient outcomes, tailor personalized therapies, and improve efficacy while minimizing adverse effects. This approach enhances clinical decision-making, leading to better management of IBD and improved patient quality of life. Future research should focus on expanding genetic profiling to refine therapeutic interventions. |
Publish Date |
2024-12-26 03:04 |
Citation |
<p>Peruhova M, Stoyanova D, Miteva DG, Kitanova M, Mirchev MB, Velikova T. Genetic factors that predict response and failure of biologic therapy in Inflammatory Bowel Disease. <i>World J Exp Med</i> 2025; 15(1): 97404</p> |
URL |
https://www.wjgnet.com/2220-315x/full/v15/i1/97404.htm |
DOI |
https://dx.doi.org/10.5493/wjem.v15.i1.97404 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345